IN DATA

Powered by 

Pharma subsidiaries

Deals analysis

Rankings

Economic data

Macro-economic indicators

INSIDE THE DEAL

Imcyse closes €21.3m Series B funding round

Imcyse has secured funding to continue developing novel immunotherapies for severe autoimmune diseases

Deals Analysis

North America extends deals value lead

North America is leading in terms of deal value, but recorded YoY decline in deals volume at -10.76%

Rankings

Which mid-sized company is leading in Europe?

Our pharma industry key list brings you the 15 leading mid-sized companies in Europe by revenue

Pharma subsidiaries

Deals analysis

Rankings

Economic data

Macro-economic indicators

02/23/2024 23:26:33
  • Home | Once more unto the (data) breach
  • In this issue
  • Contents
  • SHL Medical
  • SHL Medical Company Insight
  • Datwyler Company Insight
  • Datwyler
  • Labcorp
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • Baxter
  • Sukano Company Insight
  • Sukano
  • Comment
  • Use of off-label therapies increases the need for reliable clinical trial data
  • Unmet needs remain in the neuroendocrine tumour treatment paradigm
  • Drinking alcohol raises risk of oesophageal and other cancers
  • Verder Company Insight
  • Verder
  • RegPak
  • Avery Dennison
  • In Depth
  • Pharma cybersecurity breaches to know and learn from
  • The drugs treating alcoholism
  • In with the old: how an established vaccine is fuelling Covid-19 treatment
  • How are hospitals tackling pharmaceutical pollution?
  • After Covid-19, mRNA technology aims to revolutionise the flu shot
  • Pushing for a UK genomics revolution
  • Micronova
  • Pfeiffer Vacuum
  • HOF Sonderanlagenbau
  • In Data
  • Data: pharma subsidiaries
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
08/19/2021 00:00:00